SINOPHARM GROUP CO News

Sinopharm Holdings (01099.HK): Main business maintains growth trend, transformation and innovation continue to advance

中金公司Apr 30 19:11

Damo: Target price for Sinopharm Holdings (01099) “increase in holdings” rating reduced to HK$28

Zhitong FinanceApr 19 14:28

Sinopharm Holdings (1099.HK): Shareholders' equity increased 6.2% year-on-year in '23, gross margin is still declining

第一上海Apr 3 00:00

Sinopharm Holdings (1099.HK): 2023 results slightly lower than expected; high dividend rate expected to continue

華興證券Mar 28 00:00

Sinopharm Holdings (1099.HK): Expense Control Continues to Deepen and Expect Steady Growth in Performance

中信建投證券Mar 26 16:11

Sinopharm Holdings (01099.HK): Performance is in line with expectations, and the cost rate is further optimized

中金公司Mar 25 19:16

Daehan Rating | Daiwa: First Sinopharm Holdings “Buy” Rating and Target Price HK$25

Gelonghui FinanceMar 13 13:10

Nomura Adjusts Sinopharm Group's Price Target to HK$32.39 Form HK$33.31, Keeps at Buy

MT NewswiresMar 11 17:02

Daimo: Yosinopharm Holdings (01099) “increase in holdings” rating, target price lowered to HK$29

Zhitong FinanceDec 21, 2023 10:25

Research Report Nuggets | CICC: Lowering the target price of Sinopharm Holdings to HK$26 due to a decline in the average valuation of the industry

Gelonghui FinanceNov 2, 2023 17:38

Sinopharm Holdings (1099.HK): Short-term performance under pressure, optimistic about Q4 month-on-month improvement

中信建投證券Nov 2, 2023 16:12

Sinopharm Holdings (01099.HK): Performance was in line with expectations, sales and financial expenses declined slightly in the 1st to 3rd quarter

中金公司Nov 1, 2023 11:26

Bank Ratings｜Dahua Jixian: Maintaining Sinopharm Holdings' “Buy” Rating, Target Price Lowered to HK$25

Gelonghui FinanceNov 1, 2023 11:20

Nomura: Maintaining the “buy” rating of Sinopharm Holdings (01099), the target price dropped to HK$33.31

Zhitong FinanceOct 24, 2023 14:34

Research Report Nuggets | Huatai Securities: Maintaining Sinopharm Holdings's “buy” rating target price of HK$32.36

Gelonghui FinanceAug 30, 2023 10:17

Sinopharm Holdings (1099.HK): H1's performance is growing steadily, and the advantages of integrated transformation are obvious

中信建投證券Aug 29, 2023 15:26

Citigroup: Maintains the “buy” rating of Sinopharm Holdings (01099) and lowers the target price to HK$26

Zhitong FinanceAug 29, 2023 10:41

Sinopharm Holdings (01099.HK): Performance is in line with expectations, retail operating profit margin increases

中金公司Aug 28, 2023 20:26

Sinopharm Holdings (1099.HK): Three major businesses are strong, and market share continues to be consolidated

華泰證券Aug 28, 2023 00:00

Nomura: Maintaining Sinopharm Holdings' (01099) “Buy” Rating Target Price Reduced to HK$36.28

Zhitong FinanceJul 28, 2023 15:53